553 related articles for article (PubMed ID: 17314675)
21. MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas.
Correa-Medina M; Bravo-Egana V; Rosero S; Ricordi C; Edlund H; Diez J; Pastori RL
Gene Expr Patterns; 2009 Apr; 9(4):193-9. PubMed ID: 19135553
[TBL] [Abstract][Full Text] [Related]
22. miRNA-125b regulates TNF-α production in CD14+ neonatal monocytes via post-transcriptional regulation.
Huang HC; Yu HR; Huang LT; Huang HC; Chen RF; Lin IC; Ou CY; Hsu TY; Yang KD
J Leukoc Biol; 2012 Jul; 92(1):171-82. PubMed ID: 22581933
[TBL] [Abstract][Full Text] [Related]
23. Posttranscriptional regulation of connexin-43 expression.
Klotz LO
Arch Biochem Biophys; 2012 Aug; 524(1):23-9. PubMed ID: 22464988
[TBL] [Abstract][Full Text] [Related]
24. Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets.
Lau P; Frigerio CS; De Strooper B
Ageing Res Rev; 2014 Sep; 17():43-53. PubMed ID: 24607832
[TBL] [Abstract][Full Text] [Related]
25. Reduced KIAA0471 mRNA expression in Alzheimer's patients: a new candidate gene product linked to the disease?
de Yebra L; Adroer R; de Gregorio-Rocasolano N; Blesa R; Trullas R; Mahy N
Hum Mol Genet; 2004 Nov; 13(21):2607-12. PubMed ID: 15367492
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs: potential regulators involved in human anencephaly.
Zhang Z; Chang H; Li Y; Zhang T; Zou J; Zheng X; Wu J
Int J Biochem Cell Biol; 2010 Feb; 42(2):367-74. PubMed ID: 19962448
[TBL] [Abstract][Full Text] [Related]
27. Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration.
Hébert SS; Papadopoulou AS; Smith P; Galas MC; Planel E; Silahtaroglu AN; Sergeant N; Buée L; De Strooper B
Hum Mol Genet; 2010 Oct; 19(20):3959-69. PubMed ID: 20660113
[TBL] [Abstract][Full Text] [Related]
28. [Progress of research on microRNA and Alzheimer's disease].
Dong SH; Wang T; Xiao SF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Feb; 30(1):64-6. PubMed ID: 23450482
[TBL] [Abstract][Full Text] [Related]
29. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P
Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076
[TBL] [Abstract][Full Text] [Related]
30. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus.
Vogelsberg-Ragaglia V; Schuck T; Trojanowski JQ; Lee VM
Exp Neurol; 2001 Apr; 168(2):402-12. PubMed ID: 11259128
[TBL] [Abstract][Full Text] [Related]
31. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells.
Zhao Y; Bhattacharjee S; Jones BM; Hill J; Dua P; Lukiw WJ
Mol Neurobiol; 2014 Aug; 50(1):97-106. PubMed ID: 24293102
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-139 modulates Alzheimer's-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2.
Tang Y; Bao JS; Su JH; Huang W
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28218780
[TBL] [Abstract][Full Text] [Related]
33. A functional variant in the miR-142 promoter modulating its expression and conferring risk of Alzheimer disease.
Ghanbari M; Munshi ST; Ma B; Lendemeijer B; Bansal S; Adams HH; Wang W; Goth K; Slump DE; van den Hout MCGN; van IJcken WFJ; Bellusci S; Pan Q; Erkeland SJ; de Vrij FMS; Kushner SA; Ikram MA
Hum Mutat; 2019 Nov; 40(11):2131-2145. PubMed ID: 31322790
[TBL] [Abstract][Full Text] [Related]
34. Hippocampal
Méndez-López I; Blanco-Luquin I; Sánchez-Ruiz de Gordoa J; Urdánoz-Casado A; Roldán M; Acha B; Echavarri C; Zelaya V; Jericó I; Mendioroz M
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781626
[TBL] [Abstract][Full Text] [Related]
35. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96.
Ubhi K; Rockenstein E; Kragh C; Inglis C; Spencer B; Michael S; Mante M; Adame A; Galasko D; Masliah E
Eur J Neurosci; 2014 Mar; 39(6):1026-1041. PubMed ID: 24304186
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-β Homeostasis, and Deregulated Expression of Long Noncoding RNAs.
Magistri M; Velmeshev D; Makhmutova M; Faghihi MA
J Alzheimers Dis; 2015; 48(3):647-65. PubMed ID: 26402107
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains.
Satoh J
J Pharmacol Sci; 2010; 114(3):269-75. PubMed ID: 20953120
[TBL] [Abstract][Full Text] [Related]
38. [Abnormal expression of microRNAs in the hippocampus of Ts65Dn mice].
Zhang YJ; He XJ; Liu YJ; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):173-8. PubMed ID: 20396359
[TBL] [Abstract][Full Text] [Related]
39. microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.
Salta E; De Strooper B
FASEB J; 2017 Feb; 31(2):424-433. PubMed ID: 28148775
[TBL] [Abstract][Full Text] [Related]
40. Revealing post-transcriptional microRNA-mRNA regulations in Alzheimer's disease through ensemble graphs.
Armañanzas R
BMC Genomics; 2018 Sep; 19(Suppl 7):668. PubMed ID: 30255799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
